61 related articles for article (PubMed ID: 19665144)
1. Effects of epidermal growth factor receptor inhibitor genistein on proliferative cholangitis in rats.
Jiang L; Jiang LS; Yan LN; Li FY; Wang W; Cheng NS; Wen TF
J Surg Res; 2010 Jul; 162(1):59-67. PubMed ID: 19665144
[TBL] [Abstract][Full Text] [Related]
2. Suppression of proliferative cholangitis in a rat model with direct adenovirus-mediated retinoblastoma gene transfer to the biliary tract.
Terao R; Honda K; Hatano E; Uehara T; Yamamoto M; Yamaoka Y
Hepatology; 1998 Sep; 28(3):605-12. PubMed ID: 9731547
[TBL] [Abstract][Full Text] [Related]
3. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.
Yoshida M; Yamamoto N; Nitta T; Uehara T; Terao R; Hatano E; Iimuro Y; Yamaoka Y
J Surg Res; 2002 Feb; 102(2):95-101. PubMed ID: 11796004
[TBL] [Abstract][Full Text] [Related]
4. Suppression of proliferative cholangitis in a rat model by local delivery of paclitaxel.
Park SM; Choi JW; Kim ST; Cho MC; Sung RH; Jang LC; Park JW; Lee SP; Park YH
J Hepatobiliary Pancreat Surg; 2003; 10(2):176-82. PubMed ID: 14505153
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis.
Li F; Zhou Y; Cheng N; Mao H; Jiang L; Li N; Li Q; de Jong MC; Pawlik TM
J Surg Res; 2011 Mar; 166(1):87-94. PubMed ID: 20097367
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated p53 gene transfer to the bile duct by direct administration into the bile in a rat cholangitis model.
Kojima Y; Honda K; Kotegawa H; Kushihata F; Kobayashi N; Liu B; Yokoyama KK
J Surg Res; 2005 Sep; 128(1):126-31. PubMed ID: 16005898
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen shRNA treatment attenuates chronic proliferative cholangitis in rats.
Li FY; Cheng NS; Cheng JQ; Mao H; Zhou Y; Jiang LS; Li N
J Gastroenterol Hepatol; 2009 May; 24(5):920-6. PubMed ID: 19032457
[TBL] [Abstract][Full Text] [Related]
8. Genistein regulation of transforming growth factor-alpha, epidermal growth factor (EGF), and EGF receptor expression in the rat uterus and vagina.
Brown NM; Lamartiniere CA
Cell Growth Differ; 2000 May; 11(5):255-60. PubMed ID: 10845426
[TBL] [Abstract][Full Text] [Related]
9. Dynamic profiling of estrogen receptor and epidermal growth factor signaling in the uteri of genistein- and estrogen-treated rats.
Cotroneo MS; Fritz WA; Lamartiniere CA
Food Chem Toxicol; 2005 May; 43(5):637-45. PubMed ID: 15778002
[TBL] [Abstract][Full Text] [Related]
10. EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR.
Liu SH; Chen XF; Xie ZB; Zhou J
Int J Mol Med; 2019 Jul; 44(1):79-88. PubMed ID: 31115490
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
12. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.
Uckun FM; Narla RK; Zeren T; Yanishevski Y; Myers DE; Waurzyniak B; Ek O; Schneider E; Messinger Y; Chelstrom LM; Gunther R; Evans W
Clin Cancer Res; 1998 May; 4(5):1125-34. PubMed ID: 9607569
[TBL] [Abstract][Full Text] [Related]
13. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis.
Napoli J; Prentice D; Niinami C; Bishop GA; Desmond P; McCaughan GW
Hepatology; 1997 Sep; 26(3):624-33. PubMed ID: 9303492
[TBL] [Abstract][Full Text] [Related]
14. Activation of epidermal growth factor receptor during corneal epithelial migration.
Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649
[TBL] [Abstract][Full Text] [Related]
15. Ascending cholangitis provokes IL-8 and MCP-1 expression and promotes inflammatory cell infiltration in the cholestatic rat liver.
Hsieh CS; Huang CC; Wu JJ; Chaung HC; Wu CL; Chang NK; Chang YM; Chou MH; Chuang JH
J Pediatr Surg; 2001 Nov; 36(11):1623-8. PubMed ID: 11685687
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor in chronic bile duct obstructed rats: implications for maintenance of hepatocellular mass.
Oguey D; Marti U; Reichen J
Eur J Cell Biol; 1992 Oct; 59(1):187-95. PubMed ID: 1468440
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of chemical biliary duct embolization for chemical hepatectomy.
Li FY; Cheng JQ; Li N; He S; Zhang MM; Dong JH; Jiang LS; Cheng NS
J Gastroenterol Hepatol; 2006 May; 21(5):880-6. PubMed ID: 16704540
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat.
Saperstein LA; Jirtle RL; Farouk M; Thompson HJ; Chung KS; Meyers WC
Hepatology; 1994 Feb; 19(2):412-7. PubMed ID: 8294098
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
[TBL] [Abstract][Full Text] [Related]
20. Early weaning accelerates the differentiation of mucous neck cells in rat gastric mucosa: possible role of TGFalpha/EGFR.
Osaki LH; Curi MA; Alvares EP; Gama P
Differentiation; 2010 Jan; 79(1):48-56. PubMed ID: 19783352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
